Drug class · Oncology & immunology
Kinase inhibitors Drug Codes & NDCs
Small-molecule drugs that inhibit one or more protein kinases. Most are oral products dispensed by pharmacies.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Imbruvicaibrutinib | Ibrutinib 280 mg/1 | Tablet, Film coatedOral | Pharmacyclics LLC | 57962-280 |
| Imbruvicaibrutinib | Ibrutinib 420 mg/1 | Tablet, Film coatedOral | Pharmacyclics LLC | 57962-420 |
| Imkeldiimatinib oral | Imatinib mesylate 80 mg/mL | SolutionOral | Shorla Oncology Inc., | 81927-201 |
| Inlytaaxitinib | Axitinib 1 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0145 |
| Inlytaaxitinib | Axitinib 5 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0151 |
| Inlytaaxitinib | Axitinib 1 mg/1 | Tablet, Film coatedOral | U.S. Pharmaceuticals | 63539-026 |
| Inlytaaxitinib | Axitinib 5 mg/1 | Tablet, Film coatedOral | U.S. Pharmaceuticals | 63539-044 |
| Iressagefitinib | Gefitinib 250 mg/1 | Tablet, CoatedOral | AstraZeneca Pharmaceuticals LP | 0310-0482 |
| Itovebiinavolisib | Inavolisib 9 mg/1 | Tablet, Film coatedOral | Genentech, Inc. | 50242-079 |
| Itovebiinavolisib | Inavolisib 3 mg/1 | Tablet, Film coatedOral | Genentech, Inc. | 50242-084 |
| Jakafiruxolitinib | Ruxolitinib 5 mg/1 | TabletOral | Incyte Corporation | 50881-005 |
| Jakafiruxolitinib | Ruxolitinib 10 mg/1 | TabletOral | Incyte Corporation | 50881-010 |
| Jakafiruxolitinib | Ruxolitinib 15 mg/1 | TabletOral | Incyte Corporation | 50881-015 |
| Jakafiruxolitinib | Ruxolitinib 20 mg/1 | TabletOral | Incyte Corporation | 50881-020 |
| Jakafiruxolitinib | Ruxolitinib 25 mg/1 | TabletOral | Incyte Corporation | 50881-025 |
| Jakafi XRruxolitinib | Ruxolitinib 11 mg/1 | Tablet, Extended releaseOral | Incyte Corporation | 50881-011 |
| Jakafi XRruxolitinib | Ruxolitinib 22 mg/1 | Tablet, Extended releaseOral | Incyte Corporation | 50881-022 |
| Jakafi XRruxolitinib | Ruxolitinib 33 mg/1 | Tablet, Extended releaseOral | Incyte Corporation | 50881-033 |
| Jakafi XRruxolitinib | Ruxolitinib 44 mg/1 | Tablet, Extended releaseOral | Incyte Corporation | 50881-044 |
| Jakafi XRruxolitinib | Ruxolitinib 55 mg/1 | Tablet, Extended releaseOral | Incyte Corporation | 50881-055 |
| Jaypircapirtobrutinib | Pirtobrutinib 50 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-6902 |
| Jaypircapirtobrutinib | Pirtobrutinib 100 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-7026 |
| Joenjaleniolisib | Leniolisib phosphate 40 mg/1 | Tablet, Film coatedOral | Pharming Healthcare Inc. | 71274-140 |
| Joenjaleniolisib | Leniolisib phosphate 50 mg/1 | Tablet, Film coatedOral | Pharming Healthcare Inc. | 71274-150 |
| Joenjaleniolisib | Leniolisib phosphate 70 mg/1 | Tablet, Film coatedOral | Pharming Healthcare Inc. | 71274-170 |